Medgend Icon







discontinued


Search instead for tension xr

Aptensio Xr FDA Approved Drugs

APTENSIO XR [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral capsule, extended release)
15mg (oral capsule, extended release)
20mg (oral capsule, extended release)
30mg (oral capsule, extended release)
40mg (oral capsule, extended release)
50mg (oral capsule, extended release)
60mg (oral capsule, extended release)
Rhodes PharmsApr 17, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CONCERTA [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
18mg (oral tablet, extended release)
27mg (oral tablet, extended release)
36mg (oral tablet, extended release)
54mg (oral tablet, extended release)
Janssen PharmsAug 1, 2000
  • For claims 1-3,6-13,16-24 and 26-32: method of treating adhd.
  • For claims 1-4,6-14,16-24 and 26-32: method of treating adhd in children 6 years of age and older and adolescents.
  • Method of treating adhd in children 6 years of age and older and adolescents.
  • Method of treating adhd.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METADATE CD [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral capsule, extended release)
20mg (oral capsule, extended release)
30mg (oral capsule, extended release)
40mg (oral capsule, extended release)
50mg (oral capsule, extended release)
60mg (oral capsule, extended release)
Ucb IncMay 27, 2003
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METADATE ER [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
20mg (oral tablet, extended release)
Ucb IncJun 1, 1988
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METHYLIN [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg/5ml (oral solution)
5mg/5ml (oral solution)
MallinckrodtDec 19, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METHYLIN ER [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral tablet, extended release)
20mg (oral tablet, extended release)
Mallinckrodt IncMay 9, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METHYLPHENIDATE HYDROCHLORIDE [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral tablet)
10mg/5ml (oral solution)
18mg (oral tablet, extended release)
2.5mg (oral tablet, chewable)
20mg (oral tablet)
27mg (oral tablet, extended release)
30mg (oral capsule, extended release)
36mg (oral tablet, extended release)
40mg (oral capsule, extended release)
50mg (oral capsule, extended release)
54mg (oral tablet, extended release)
5mg/5ml (oral solution)
60mg (oral capsule, extended release)
Abhai IncMay 11, 2017
Abhai LlcJun 9, 2015
Actavis Labs Fl IncAug 29, 1997
Ascent Pharms IncSep 22, 2015
Barr Labs IncOct 15, 2014
Cnty Line PharmsFeb 29, 2016
Impax Labs IncJul 28, 2016
MallinckrodtNov 27, 1998
Mallinckrodt IncSep 29, 2015
Nostrum Labs IncJan 26, 2017
Novel Labs IncFeb 25, 2015
Sun Pharm Inds IncMar 15, 2012
Tedor Pharma IncNov 7, 2016
Teva PharmsJul 19, 2012
Ucb IncApproved Prior To Jan 1, 1982
Vintage PharmsSep 23, 2014
Tris Pharma IncJul 23, 2010
Kremers Urban PharmsJul 9, 2013
Mylan Pharms IncOct 21, 2016
Mayne PharmaDec 1, 2011
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

QUILLICHEW ER [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
20mg (oral tablet, extended release, chewable)
30mg (oral tablet, extended release, chewable)
40mg (oral tablet, extended release, chewable)
Pfizer IncDec 4, 2015
  • A method of providing a subject with therapeutically effective amount of racemic methylphenidate by orally administering to said subject a single methylphenidate extended release chewable tablet according to claim 1.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

QUILLIVANT XR [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
5mg/ml (oral for suspension, extended release)
Nextwave PharmsSep 27, 2012
  • Method of treating attention deficit hyperactivity disorder by administering the composition of claim 1.
  • Treating a patient having a condition susceptible to treatment with methylphenidate, such as adhd, by administering the formulation recited in claims 1 or 2.
  • Treatment of a patient by administering the formulation recited in claim 1 or claim 23.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RITALIN [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral tablet)
20mg (oral tablet)
5mg (oral tablet)
NovartisApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RITALIN LA [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
10mg (oral capsule, extended release)
20mg (oral capsule, extended release)
30mg (oral capsule, extended release)
40mg (oral capsule, extended release)
NovartisApr 10, 2004
  • Treatment of attention deficit hyperactivity disorder using methylphenidate bi-modal release profile extended-release capsules.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

RITALIN-SR [Methylphenidate HydrochlorideC14H19NO2ClH]
RX
-
20mg (oral tablet, extended release)
NovartisMar 30, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.